Equinox Group specializes in assessing the commercial potential of drug programs in all stages of R&D, delivering quantitative insights in disease area strategy, market access, patient share forecasting, patient flow, and epidemiology.

0+
Years Of Experience
0+
Drug Assessments

Recent Articles

Interested in doing business? Fill out the form below to get in touch or click here to schedule a meeting.